Article info
PDFExtended essay
Patient data for commercial companies? An ethical framework for sharing patients’ data with for-profit companies for research
- Correspondence to Dr Eva C Winkler, Section for Translational Medical Ethics, Department of Medical Oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg 69120, Germany; eva.winkler{at}med.uni-heidelberg.de
Citation
Patient data for commercial companies? An ethical framework for sharing patients’ data with for-profit companies for research
Publication history
- Received November 19, 2022
- Accepted April 29, 2023
- First published May 25, 2023.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Other content recommended for you
- How should we think about clinical data ownership?
- Should free-text data in electronic medical records be shared for research? A citizens’ jury study in the UK
- Patients’ and public views and attitudes towards the sharing of health data for research: a narrative review of the empirical evidence
- Glossary for public health surveillance in the age of data science
- The social licence for research: why care.data ran into trouble
- Control, trust and the sharing of health information: the limits of trust
- Meta consent: a flexible and autonomous way of obtaining informed consent for secondary research
- Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients
- Can the NHS be a learning healthcare system in the age of digital technology?
- Webinar report: stakeholder perspectives on informed consent for the use of genomic data by commercial entities